VWF:AG, VWF:CBA and VWF:AG/ADAMTS13 activity were significantly increased in COVID-19 (+) patients within the overweight (25–29.9 kg/m2) and obese (>30 kg/m2) BMI groupings (Table 3). This evidence concerns the gene VWF and COVID-19.